Search Results - Anna Vilalta-Lacarra
- Showing 1 - 6 results of 6
-
1
-
2
Impact on the Nutritional Status and Inflammation of Patients with Cancer Hospitalized after the SARS-CoV-2 Lockdown by Patricia Yárnoz-Esquíroz, Ana Chopitea, Laura Olazarán, Maite Aguas-Ayesa, Camilo Silva, Anna Vilalta-Lacarra, Javier Escalada, Ignacio Gil-Bazo, Gema Frühbeck, Javier Gómez-Ambrosi
Published 2022-07-01
Article -
3
Association of depression phenotypes and antidepressant treatment with mortality due to cancer and other causes: a community-based cohort study by Anna Vilalta-Lacarra, Joan Vilalta-Franch, Domènec Serrano-Sarbosa, Domènec Serrano-Sarbosa, Domènec Serrano-Sarbosa, Ruth Martí-Lluch, Ruth Martí-Lluch, Jaume Marrugat, Jaume Marrugat, Josep Garre-Olmo, Josep Garre-Olmo
Published 2023-08-01
Article -
4
Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation by Ander Puyalto, María Rodríguez-Remírez, Inés López, Irati Macaya, Elizabeth Guruceaga, María Olmedo, Anna Vilalta-Lacarra, Connor Welch, Sergio Sandiego, Silvestre Vicent, Karmele Valencia, Alfonso Calvo, Ruben Pio, Luis E. Raez, Christian Rolfo, Daniel Ajona, Ignacio Gil-Bazo
Published 2024-04-01
Article -
5
A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer by Ander Puyalto, Ander Puyalto, Ander Puyalto, María Rodríguez-Remírez, María Rodríguez-Remírez, María Rodríguez-Remírez, Inés López, Inés López, Fabiola Iribarren, Fabiola Iribarren, Jon Ander Simón, Jon Ander Simón, Jon Ander Simón, Marga Ecay, Marga Ecay, María Collantes, María Collantes, Anna Vilalta-Lacarra, Anna Vilalta-Lacarra, Alejandro Francisco-Cruz, Jose Luis Solórzano, Jose Luis Solórzano, Sergio Sandiego, Iván Peñuelas, Iván Peñuelas, Iván Peñuelas, Alfonso Calvo, Alfonso Calvo, Alfonso Calvo, Daniel Ajona, Daniel Ajona, Daniel Ajona, Ignacio Gil-Bazo, Ignacio Gil-Bazo, Ignacio Gil-Bazo, Ignacio Gil-Bazo, Ignacio Gil-Bazo
Published 2023-09-01
Article -
6
Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients by Benito Farina, Ana Delia Ramos Guerra, David Bermejo-Peláez, Carmelo Palacios Miras, Andrés Alcazar Peral, Guillermo Gallardo Madueño, Jesús Corral Jaime, Anna Vilalta-Lacarra, Jaime Rubio Pérez, Arrate Muñoz-Barrutia, German R. Peces-Barba, Luis Seijo Maceiras, Ignacio Gil-Bazo, Manuel Dómine Gómez, María J. Ledesma-Carbayo
Published 2023-03-01
Article